Clinical Trials Browser

Has results × Maximum Tolerated Dose × 1 year × Clear all

NCT03663218 2026-03-18

PREPARE SBRT

Phase NA Active not recruiting

16 enrolled 9 charts

Prostatic Neoplasms

NCT03838367 2025-09-09

Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC

Phase 1/2 Terminated

10 enrolled 15 charts

Triple Negative Breast Neoplasms